Your browser doesn't support javascript.
loading
Shear-sensitive nanocapsule drug release for site-specific inhibition of occlusive thrombus formation.
Molloy, C P; Yao, Y; Kammoun, H; Bonnard, T; Hoefer, T; Alt, K; Tovar-Lopez, F; Rosengarten, G; Ramsland, P A; van der Meer, A D; van den Berg, A; Murphy, A J; Hagemeyer, C E; Peter, K; Westein, E.
Afiliación
  • Molloy CP; Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
  • Yao Y; Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
  • Kammoun H; Haematopoiesis and Leukocyte Biology, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia.
  • Bonnard T; Nano Biotechnology Laboratory, Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.
  • Hoefer T; Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
  • Alt K; Nano Biotechnology Laboratory, Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.
  • Tovar-Lopez F; School of Engineering, RMIT University, Melbourne, Victoria, Australia.
  • Rosengarten G; School of Engineering, RMIT University, Melbourne, Victoria, Australia.
  • Ramsland PA; School of Science, RMIT University, Bundoora, Victoria, Australia.
  • van der Meer AD; Centre for Biomedical Research, Burnet Institute, Melbourne, Victoria, Australia.
  • van den Berg A; Department of Immunology, Monash University, Melbourne, Victoria, Australia.
  • Murphy AJ; Department of Surgery at Austin Health, University of Melbourne, Heidelberg, Victoria, Australia.
  • Hagemeyer CE; MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, the Netherlands.
  • Peter K; MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, the Netherlands.
  • Westein E; Haematopoiesis and Leukocyte Biology, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia.
J Thromb Haemost ; 15(5): 972-982, 2017 05.
Article en En | MEDLINE | ID: mdl-28267256
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos / Arteriopatías Oclusivas / Trombosis / Inhibidores de Agregación Plaquetaria / Agregación Plaquetaria / Sistemas de Liberación de Medicamentos / Nanocápsulas / Fibrinolíticos Tipo de estudio: Diagnostic_studies Límite: Animals Idioma: En Revista: J Thromb Haemost Asunto de la revista: HEMATOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos / Arteriopatías Oclusivas / Trombosis / Inhibidores de Agregación Plaquetaria / Agregación Plaquetaria / Sistemas de Liberación de Medicamentos / Nanocápsulas / Fibrinolíticos Tipo de estudio: Diagnostic_studies Límite: Animals Idioma: En Revista: J Thromb Haemost Asunto de la revista: HEMATOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido